KUWAIT CITY, June 12 , (Agencies): The Ministry of Health announced it has adopted measures to possibly valuate the antibodies of the emerging corona virus (Covid-19) within a specific data that has been approved and not to evaluate or measure the number of antibodies after vaccination. The ministry said in a press statement some of these analyses detect different types of IgG-IgM antibodies, so they do not have the ability to detect special antibodies resulting from vaccination.
In a related context, the ministry said the Oxford vaccine, which is produced in Russia, is licensed and approved by the AstraZeneca company and that the manufacturing process and all procedures are under its supervision because it is the licensing company. With regard to the Oxford-AstraZeneca vaccine, the ministry stated that it has received the third batch of the vaccine after the results of its samples matched the technical specifications and ensured that they were stored in accordance with the approved temperatures and storage conditions. The sources confirmed the effectiveness of the first dose of the Oxford vaccine increases with the extended period of the second dose to more than 12 weeks, as indicated by scientific studies and realistic statistics.